$41.15
STAAR Surgical Company is a medical instruments & supplies business based in the US. STAAR Surgical Company shares (STAA) are listed on the NASDAQ and all prices are listed in US Dollars. STAAR Surgical Company employs 1,056 staff and has a trailing 12-month revenue of around $326.2 million.
What's in this guide?
Our top picks for where to buy STAAR Surgical Company stock
How to buy STAAR Surgical Company stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – STAA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy STAAR Surgical Company stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
STAAR Surgical Company stock price (NASDAQ: STAA)
Use our graph to track the performance of STAA stocks over time.STAAR Surgical Company shares at a glance
Latest market close | $41.87 |
---|---|
52-week range | $26.66 - $58.35 |
50-day moving average | $42.60 |
200-day moving average | $37.97 |
Wall St. target price | $50.59 |
PE ratio | 137.0968 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $0.31 |
Is it a good time to buy STAAR Surgical Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
STAAR Surgical Company price performance over time
Historical closes compared with the close of $41.87 from 2024-07-23
1 week (2024-07-17) | -5.34% |
---|---|
1 month (2024-06-24) | 1.75% |
3 months (2024-04-24) | -12.44% |
6 months (2024-01-24) | 39.57% |
1 year (2023-07-24) | -27.46% |
---|---|
2 years (2022-07-22) | -44.87% |
3 years (2021-07-23) | 131.88 |
5 years (2019-07-24) | 28.16% |
Is STAAR Surgical Company stock undervalued or overvalued?
Valuing STAAR Surgical Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STAAR Surgical Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
STAAR Surgical Company's P/E ratio
STAAR Surgical Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 137x. In other words, STAAR Surgical Company shares trade at around 137x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
STAAR Surgical Company's EBITDA
STAAR Surgical Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $29.9 million.
The EBITDA is a measure of a STAAR Surgical Company's overall financial performance and is widely used to measure a its profitability.
STAAR Surgical Company financials
Revenue TTM | $326.2 million |
---|---|
Gross profit TTM | $223.4 million |
Return on assets TTM | 3.38% |
Return on equity TTM | 4.18% |
Profit margin | 4.69% |
Book value | $8.00 |
Market Capitalization | $2.1 billion |
TTM: trailing 12 months
STAAR Surgical Company share dividends
We're not expecting STAAR Surgical Company to pay a dividend over the next 12 months.
Have STAAR Surgical Company's shares ever split?
STAAR Surgical Company's shares were split on a 1:2 basis on 17 May 1992. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STAAR Surgical Company shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for STAAR Surgical Company shares which in turn could have impacted STAAR Surgical Company's share price.
STAAR Surgical Company share price volatility
Over the last 12 months, STAAR Surgical Company's shares have ranged in value from as little as $26.6554 up to $58.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STAAR Surgical Company's is 0.597. This would suggest that STAAR Surgical Company's shares are less volatile than average (for this exchange).
STAAR Surgical Company overview
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. .
Frequently asked questions
What percentage of STAAR Surgical Company is owned by insiders or institutions?Currently 0.52% of STAAR Surgical Company shares are held by insiders and 99.686% by institutions. How many people work for STAAR Surgical Company?
Latest data suggests 1,056 work at STAAR Surgical Company. When does the fiscal year end for STAAR Surgical Company?
STAAR Surgical Company's fiscal year ends in December. Where is STAAR Surgical Company based?
STAAR Surgical Company's address is: 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630 What is STAAR Surgical Company's ISIN number?
STAAR Surgical Company's international securities identification number is: US8523123052 What is STAAR Surgical Company's CUSIP number?
STAAR Surgical Company's Committee on Uniform Securities Identification Procedures number is: 852312305
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question